synthet
nanoparticl
play
increasingli
signific
role
vaccin
design
develop
mani
nanoparticl
vaccin
show
improv
safeti
efficaci
convent
formul
nanoformul
structur
similar
virus
nanoscal
pathogen
organ
serv
key
select
pressur
drive
evolut
immun
system
result
mechan
behind
benefit
nanoparticl
vaccin
often
find
analogu
interact
dynam
immun
system
virus
review
cover
advanc
vaccin
nanotechnolog
perspect
advantag
viru
mimicri
toward
immun
potenti
provid
overview
differ
type
nanomateri
util
nanoparticl
vaccin
develop
includ
function
strategi
bestow
nanoparticl
viruslik
featur
understand
human
immun
vaccin
mechan
continu
evolv
recogn
fundament
semblanc
synthet
nanoparticl
virus
may
offer
explan
superior
nanoparticl
vaccin
convent
vaccin
may
spur
new
design
rational
futur
vaccin
research
nanoformul
pois
provid
solut
toward
press
emerg
human
diseas
vaccin
process
introduc
antigen
materi
activ
individu
immun
system
develop
adapt
immun
pathogen
proven
success
costeffect
prophylact
measur
infecti
diseas
vaccin
respons
erad
effect
manag
mani
major
diseas
includ
smallpox
measl
mump
rubella
diphtheria
tetanu
pertussi
polio
yellow
fever
despit
mani
exampl
success
vaccin
mani
diseas
threat
human
immunodefici
viru
hiv
tuberculosi
dengu
malaria
lack
effect
prophylact
measur
thu
develop
new
vaccin
formul
technolog
remain
ongo
quest
convent
vaccin
formul
compris
biolog
materi
form
attenu
virus
kill
pathogen
subunit
protein
antigen
platform
distinct
advantag
shortcom
frequent
present
tradeoff
safeti
efficaci
exampl
live
attenu
vaccin
excel
induc
long
last
protect
immun
strong
immun
respons
live
natur
pose
safeti
concern
especi
individu
may
immunocompromis
hand
subunit
vaccin
safer
administ
less
immunogen
less
effect
elicit
cellular
immun
diseas
protect
fig
emerg
technolog
formul
combin
advantag
live
attenu
subunit
vaccin
thu
continu
develop
aim
maxim
vaccin
safeti
potenc
last
decad
advanc
materi
engin
open
new
avenu
ivyspr
intern
publish
innov
vaccin
design
particular
synthet
nanoparticl
wide
adopt
vaccin
develop
particl
typic
nm
diamet
shown
effect
immun
potenti
vivo
capabl
induc
strong
humor
cellular
immun
respons
antigen
target
compar
live
attenu
viral
vaccin
synthet
nanoparticl
promis
better
safeti
profil
nonrepl
natur
also
readili
amen
differ
infecti
pathogen
holist
view
mani
advantag
nanoparticl
vaccin
may
attribut
intrins
semblanc
natur
virus
fig
mani
viral
featur
nanoscal
morpholog
repetit
multival
antigen
display
control
antigenadjuv
deliveri
conduc
immun
process
physiolog
cellular
level
immun
system
evolv
effect
respond
infecti
viral
nanoparticl
come
surpris
nanoformul
adopt
viruslik
featur
potent
convent
subunit
formul
date
numer
nanoparticlebas
platform
examin
vaccin
applic
mani
demonstr
encourag
efficaci
mani
press
infecti
threat
includ
malaria
influenza
ebola
hiv
also
worth
note
rapidli
expand
field
nanoparticlebas
anticanc
vaccin
exploit
nanotechnolog
enhanc
induct
antigenspecif
cellular
immun
respons
oncolog
malign
mani
design
consider
nanoparticl
vaccin
trace
fundament
interact
dynam
virus
immun
system
upon
close
scrutini
viruslik
mimicri
term
size
geometri
antigen
display
adjuvant
commonli
observ
among
vaccin
nanoformul
light
emerg
landscap
nanoparticl
vaccin
research
review
highlight
underli
principl
behind
advantag
nanoparticl
vaccin
first
section
commonli
use
biomateri
lipid
polym
inorgan
compound
review
context
vaccin
applic
section
ensu
variou
nanoparticl
design
aspect
explor
virusmimet
perspect
includ
lymphat
deliveri
antigen
display
interact
immun
cell
lastli
highlight
conjug
strategi
coupl
subunit
protein
antigen
nanocarri
review
also
summar
variou
strategi
conjug
antigensadjuv
nanocarri
review
aim
provid
holist
view
recent
advanc
next
gener
immunomodulatori
vaccin
toward
mimick
viral
featur
prepar
nanoparticul
rang
nm
size
first
step
prior
subsequ
vaccin
develop
therefor
imper
understand
variou
materi
properti
nanoparticl
prepar
divers
rang
nanomateri
biomed
research
encompass
wide
rang
organ
inorgan
matter
phospholipid
polym
metal
silica
carbon
fig
nanomateri
modifi
provid
function
stabl
interfac
differ
biomed
applic
context
vaccin
mani
nanocarri
modifi
trigger
specif
immun
respons
analog
natur
defens
mechan
viral
invas
follow
section
summar
differ
synthet
nanoparticl
use
vaccin
applic
overview
functionaliz
immunolog
adjuvant
liposom
selfassembl
spheric
vesicl
consist
phospholipid
bilay
aqueou
inner
core
prepar
phospholipid
fattyacid
chain
defin
length
satur
choic
phospholipid
addit
cholesterol
influenc
liposom
stabil
perform
vesicl
unilamellar
structur
one
layer
phospholipid
multilamellar
structur
sever
concentr
phospholipid
shell
platform
highli
versatil
cargo
deliveri
allow
incorpor
hydrophil
molecul
inner
core
hydrophob
molecul
within
phospholipid
bilay
antigen
adjuv
may
thu
incorpor
liposom
base
lipophil
lipid
bilay
structur
liposom
structur
analog
envelop
virus
form
bud
infect
cell
wrap
piec
cell
plasma
membran
inher
semblanc
viral
particl
may
help
explain
innat
adjuvant
liposom
upon
incorpor
protein
peptid
antigen
numer
antigen
target
rang
toxoid
viral
antigen
bacteri
antigen
observ
elicit
enhanc
humor
respons
follow
liposom
incorpor
mechanist
studi
shed
light
liposom
adjuvant
instanc
liposom
shown
capabl
modul
cell
mediat
immun
respons
reflect
facilit
antigen
process
via
classic
mhc
mhc
ii
pathway
liposom
also
report
promot
develop
cellindepend
b
cell
immun
respons
potenti
promot
longterm
immun
develop
tcell
memori
addit
innat
adjuvant
liposom
incorpor
plethora
adjuv
rang
small
molecul
glycolipid
oligodeoxynucleotid
cyclic
dinucleotid
structur
fluiditi
liposom
offer
flexibl
platform
modif
toward
viru
mimicri
exampl
develop
virosom
fusion
vesicl
prepar
viral
particl
synthet
liposom
adapt
highlight
fundament
similar
liposom
virus
deriv
membran
vesicl
virus
virosom
consist
liposomelik
lipid
vesicl
viral
envelop
glycoprotein
fusion
vesicl
retain
viral
characterist
ie
epitop
present
appli
drug
deliveri
vaccin
purpos
applic
platform
vaccin
candid
demonstr
extens
use
influenza
virusderiv
virosom
studi
appli
virosom
antiinfluenza
vaccin
derivat
influenza
virosom
shown
noninfect
genet
materi
remov
upon
vivo
administr
virosom
rapidli
uptaken
antigen
present
cell
turn
activ
numer
immun
cell
immun
virosom
report
reactiv
influenzaspecif
memori
cell
subsequ
support
prolifer
antigenspecif
effector
cell
lead
enhanc
antiinfluenza
immun
respons
besid
influenzabas
virosom
induct
cytotox
lymphocyt
respons
demonstr
sendai
virusbas
carrier
system
load
ovalbumin
ova
demonstr
sendai
virosom
fuse
ova
elicit
stronger
ctl
respons
model
antigen
liposom
may
also
modifi
enhanc
stabil
carrier
manner
analog
virus
employ
viral
matrix
protein
stabil
lipid
envelop
studi
moon
et
al
interbilayercorsslink
multilamellar
vesicl
prepar
coval
crosslink
multipl
layer
liposom
via
thiol
chemistri
multilamellar
liposom
show
ad
stabil
owe
short
coval
bond
crosslink
adjac
lipid
layer
within
vesicl
wall
modif
serv
address
shortcom
liposom
facilit
enhanc
antigen
encapsul
increas
particl
stabil
also
belong
class
lipidbas
nanoparticl
emerg
class
lipoplex
consist
cation
lipid
deriv
complex
nucleic
acid
immunostimulatori
rna
mrna
encod
specif
antigen
target
formul
lipoplex
trigger
immun
respons
function
lipoplex
liken
immun
respons
induct
rna
virus
rna
deliv
intracellularli
lipoplex
activ
innat
immun
receptor
lead
upregul
type
interferon
may
trigger
multitud
downstream
immunolog
pathway
concurr
rna
translat
antigen
interest
therebi
promot
antigenspecif
immun
respons
lipoplex
carri
mrna
target
antigen
recent
shown
phase
clinic
trial
induc
strong
cellular
respons
tumor
antigen
human
wide
varieti
polym
appli
develop
nanoparticl
vaccin
synthet
polymer
nanoparticl
typic
solid
particl
nm
nm
attract
platform
vaccin
deliveri
antigen
adjuv
either
surfac
attach
interior
load
insid
nanoparticl
particular
control
releas
biomolecul
one
strongest
advantag
polymer
nanoparticl
releas
kinet
regul
tune
copolym
composit
molecular
weight
typic
polymer
nanoparticl
form
via
selfassembl
amphiphil
copolym
emuls
nanoprecipit
process
notabl
polymer
nanoparticl
vaccin
develop
follow
poli
lacticcoglycol
acid
plga
one
commonli
use
polym
biomed
applic
plgabas
nanoparticl
known
biodegrad
nontox
nonimmunogen
upon
administr
polym
degrad
lactic
acid
glycol
acid
vivo
safe
metabolis
bodi
vaccin
applic
plga
nanoparticl
provid
robust
platform
antigen
function
use
carri
antigen
deriv
variou
pathogen
surfac
conjug
interior
encapsul
antigen
includ
deriv
plasmodium
vivax
hepat
b
viru
hbv
bacillu
anthraci
tetanu
toxin
model
antigen
ovalbumin
associ
plgabas
deliveri
system
enhanc
immun
potenti
adjuv
also
encapsul
chemic
attach
plga
polym
backbon
control
deliveri
enhanc
immun
respons
natur
polym
base
polysaccharid
pullulan
algin
chitosan
explor
nanoparticl
vaccin
prepar
particular
chitosanbas
nanoparticl
wide
studi
due
biocompat
biodegrad
nontox
natur
abil
easili
modifi
desir
shape
size
intrigu
recent
discoveri
chitosan
immun
potenti
mechan
via
dna
sens
cgasst
pathway
sting
pathway
trigger
host
cell
mani
viral
pathogen
play
major
role
innat
adapt
immun
upon
interact
dendrit
cell
chitosan
induc
type
interferon
cga
stingdepend
fashion
mediat
cellular
matur
promot
respons
chitosanbas
nanoformul
wide
adopt
vaccin
develop
exampl
includ
vaccin
clostridium
botulinum
typea
neurotoxin
neospora
caninum
hbv
newcastl
diseas
polysaccharid
polym
also
appli
enhanc
potenc
dna
vaccin
viral
bacteri
parasit
infect
polymer
nanoparticl
platform
includ
poli
acid
nanoparticl
polystyren
nanoparticl
polyalkyl
acryl
base
nanoparticl
compris
amphiphil
poli
amino
acid
selfassembl
nanomicel
hydrophil
outer
shell
hydrophob
inner
core
gener
use
encapsul
hydrophob
antigen
polystyren
nanoparticl
solid
particl
consist
polymer
styren
monom
conjug
varieti
antigen
polyalkyl
acryl
base
nanoformul
prepar
poli
methylmethacryl
pmma
poli
ethylacryl
acid
peaa
poli
propylacryl
acid
ppaa
poli
butylacryl
acid
pbaa
studi
shown
polyacrylatebas
nanoparticl
show
inher
adjuvant
sever
model
antigen
type
polym
use
nanoformul
strongli
affect
structur
properti
applic
particl
gold
chemic
inert
gold
nanoparticl
aunp
studi
extens
biomed
applic
aunp
synthes
reproduc
high
level
precis
offer
ultrast
metal
core
modif
capabl
modifi
plethora
chemic
function
group
thiol
phosphin
amin
extens
protein
antigen
aunp
use
broadli
mani
vaccin
studi
multitud
biomolecul
rang
toxin
viral
antigen
bacteri
antigen
parasit
protein
tumor
antigen
coupl
gold
nanoparticl
enhanc
immun
respons
aunp
vaccin
explor
clinic
trial
hepat
b
malaria
vaccin
also
allow
anchor
nucleic
acid
dna
vaccin
applic
aunp
modifi
differ
adjuv
well
chitosan
cpg
oligodeoxynucleotid
mani
altern
surfac
function
strategi
explor
enhanc
immun
potenti
aunp
surfac
modifi
cetyltrimethylammonium
bromid
ctab
poli
diallydimethylammonium
chlorid
pddac
polyethyleneimin
pei
use
dna
vaccin
adjuv
human
immunodefici
viru
hiv
modif
found
boost
adjuvant
aunp
carrier
gold
uniqu
malleabl
make
aunp
attract
platform
vaccinolog
studi
aunp
fabric
myriad
shape
ie
sphere
rod
cube
etc
tunabl
yet
sharpli
distribut
size
rang
nm
morpholog
tunabl
add
addit
dimens
viru
mimicri
introduct
nonspher
particl
gold
nanorod
instanc
use
vaccin
vector
deliveri
respiratori
syncyti
viru
rsv
f
protein
nonspher
particl
bear
resembl
rodlik
virus
also
frequent
observ
among
differ
viru
genera
size
modular
aunp
also
allow
examin
impact
particl
size
vaccin
deliveri
discuss
detail
later
section
review
also
worth
note
recent
discoveri
aunp
size
shape
modul
inflammatori
respons
cellular
level
studi
compar
gold
nanospher
gold
nanorod
gold
nanocub
niikura
et
al
show
wherea
nanospher
nanocub
induc
tumor
necrosi
granulocyt
macrophag
colonystimul
factor
gmcsf
nanorod
induc
via
inflammasomedepend
mechan
shapedepend
immunolog
properti
may
due
differ
surfac
energi
associ
differ
nanoscal
featur
may
promot
vari
level
stress
upon
cellular
uptak
silica
nanoparticl
offer
rang
particl
size
shape
via
control
synthesi
use
solgel
chemistri
abund
silanol
group
silica
nanoparticl
surfac
allow
function
modif
increas
specif
cellular
recognit
facilit
attach
specif
biomolecul
modul
cellular
uptak
nanoscal
pore
integr
silica
nanoparticl
yield
mesopor
silica
nanoparticl
msn
versatil
cargocarri
capac
vaccin
purpos
pore
size
surfac
function
msn
modifi
control
encapsul
releas
antigen
adjuv
choic
use
silica
nanoparticl
vaccin
applic
includ
formul
snake
venom
e
coli
porcin
circoviru
hiv
model
antigen
carbonbas
nanoparticl
carbon
nanotub
graphen
also
studi
vaccin
carrier
owe
high
aspect
ratio
larg
surfac
area
carbonbas
nanoparticl
may
carri
high
proport
antigen
immun
activ
studi
anticanc
vaccin
villa
et
al
conjug
singlewal
carbon
nanotub
swct
wilm
tumour
protein
antigen
upregul
mani
cancer
antigen
conjug
swct
show
good
uptak
dendrit
cell
macrophag
vitro
subcutan
immun
swct
promot
induct
antigenspecif
igg
contrast
free
peptid
formul
fail
induc
antibodi
respons
tumor
antigen
anoth
studi
graphen
nanosheet
use
deliv
antigen
facilit
antigen
crosspresent
cell
xu
et
al
also
demonstr
use
dual
polymermodifi
graphen
formul
effect
adjuv
enhanc
immunogen
h
pylori
deriv
antigen
alumur
b
semiconductor
quantum
dot
appli
vaccin
applic
offer
versatil
platform
nanoparticul
antigen
deliveri
ad
benefit
particl
track
studi
cambi
et
al
antigenconjug
quantum
dot
viruslik
dimens
shown
combin
antigen
deliveri
bioimag
function
enabl
immun
cell
track
follow
antigen
uptak
present
possibl
track
antigenpres
cell
vivo
along
similar
line
sen
et
al
show
quantum
dot
induc
cell
prolifer
product
vivo
traceabl
within
lymph
node
nanoparticl
platform
imag
function
includ
polymer
upconvers
nanoparticl
iron
oxid
nanoparticl
also
studi
antigen
carrier
vaccin
applic
platform
offer
capabl
examin
function
mechan
behind
benefit
nanoparticl
vaccin
one
biggest
advantag
nanoparticl
vaccin
abil
effici
drain
accumul
lymph
node
enhanc
immun
process
lymphat
system
subset
circulatori
system
consist
complex
network
vessel
tissu
organ
lymphat
vessel
conduct
lymph
differ
part
bodi
blood
exit
blood
vasculatur
becom
interstiti
fluid
lymphat
system
provid
return
rout
interstiti
fluid
blood
vessel
form
lymph
process
regul
fluid
balanc
within
tissu
underli
lymphat
system
numer
lymph
node
scatter
throughout
bodi
lymph
node
home
site
migratori
dendrit
cell
present
engulf
antigen
resid
peripher
lymphoid
organ
abund
special
macrophag
lymphocyt
play
major
role
antigen
captur
process
adapt
immun
respons
lymph
pass
lymph
node
resid
macrophag
captur
pass
antigen
word
lymphat
system
function
filter
system
bodili
fluid
trap
antigen
lymph
node
immun
process
virus
viruslik
nanoparticul
accumul
lymph
node
via
cellmedi
lymphat
deliveri
convect
lymphat
transport
cellmedi
transport
mediat
primarili
migratori
dendrit
cell
take
antigen
outsid
lymphat
system
ie
skin
lung
enter
lymph
node
via
either
high
endotheli
venul
lymph
vessel
comparison
small
protein
antigen
virus
nanoparticl
vaccin
favor
hitchhik
mechan
particul
natur
promot
receptormedi
complementmedi
intracellular
uptak
mechan
antigen
associ
nanocarri
routin
observ
effici
uptaken
dendrit
cell
compar
solubl
antigen
therebi
enabl
effect
lymph
node
deliveri
cross
present
hand
nanoscal
morpholog
virus
viruslik
particul
allow
move
freeli
lymphat
vessel
drain
lymph
node
upon
lymph
node
entri
special
subset
macrophag
respons
captur
nanoparticul
studi
lymphat
track
virus
junt
et
al
macrophag
subcapsular
sinu
medulla
lymph
node
shown
respons
lymph
node
accumul
subcutan
administ
inactiv
vesicular
stomat
viru
adenoviru
vaccinia
viru
deplet
macrophag
result
enhanc
viru
level
circul
back
blood
highlight
virus
convect
transport
lymphat
system
macrophag
role
viru
filtrat
gatekeep
function
lymph
noderesid
macrophag
serv
limit
bloodborn
infect
promot
immun
process
exploit
transport
mechan
aim
detain
virus
nanoparticl
vaccin
effect
target
immun
cell
lymph
node
deliv
antigen
adjuv
follow
administr
peripher
tissu
fig
benefit
focu
lymph
node
target
also
explain
particul
vaccin
commonli
administ
subcutan
oppos
convent
intramuscular
rout
subunit
vaccin
free
lymphat
drainag
access
immun
cell
lymph
node
follow
inject
interstitium
like
outweigh
depot
effect
afford
intramuscular
rout
lymphat
target
nanoparticl
also
observ
follow
administr
via
differ
deliveri
rout
includ
pulmonari
oral
intraperiton
rout
favor
distribut
profil
allow
tailor
nanoparticl
vaccin
toward
target
specif
immunolog
compart
differ
infecti
threat
studi
influenc
nanoparticl
size
lymph
node
target
began
scientist
aim
maxim
lymphat
deliveri
drug
treat
metastat
cancer
gener
observ
follow
subcutan
inject
liposom
smaller
nm
abl
enter
lymphat
capillari
wherea
larger
liposom
remain
inject
site
studi
oussoren
et
al
use
isotop
label
liposom
nm
diamet
lymphat
track
lymphat
uptak
found
invers
proport
liposom
size
nm
nm
nm
nm
liposom
approxim
inject
dose
enter
lymphat
system
respect
curious
despit
higher
lymphat
entri
smaller
liposom
studi
liposom
accumul
drain
lymph
node
similar
across
differ
size
formul
found
major
small
liposom
consist
eggphosphatidylcholin
eggphosphatidylglycerol
pass
lymph
node
ultim
captur
liver
spleen
result
highlight
dynam
relationship
particl
size
lymph
node
accumul
smaller
particl
like
enter
lymphat
system
also
like
evad
filter
mechan
lymph
node
author
show
incorpor
phosphotidylserin
lipid
suscept
macrophag
recognit
captur
increas
lymph
node
accumul
lipid
modif
strategi
steric
stabil
ligand
function
also
report
influenc
lymph
node
accumul
liposom
follow
lymphat
uptak
later
studi
use
solid
nanoparticl
examin
effect
particl
size
lymph
node
deliveri
echo
earlier
find
base
liposom
use
polystyren
bead
manolova
et
al
confirm
sizedepend
particl
transport
lymphat
system
upon
subcutan
deliveri
larg
particl
nm
found
associ
dendrit
cell
site
inject
small
nanoparticl
nm
could
drain
freeli
lymphat
system
effect
target
lymph
noderesid
dendrit
cell
macrophag
studi
reddi
et
al
examin
nanocarri
vaccin
deliveri
platform
pluronicstabil
polypropylen
sulfid
nanoparticl
welldefin
size
investig
use
fluoresc
microlymphangiographi
investig
show
clear
distinct
nm
nm
particl
regard
lymphat
uptak
follow
inject
mous
tail
nm
particl
effici
drain
lymphat
vessel
wherea
interstiti
transport
nm
particl
less
effici
contrast
prior
studi
liposom
nm
particl
also
show
higher
lymph
node
accumul
result
enhanc
lymph
node
deliveri
compar
nm
particl
fig
c
enhanc
lymph
node
deliveri
absent
earlier
liposom
studi
could
attribut
increas
colloid
stabil
polymer
nanoparticl
particl
abil
elicit
complement
activ
polypropylen
sulfid
particl
function
surfac
hydroxyl
group
trigger
proteolyt
cleavag
complement
protein
danger
signal
associ
complement
activ
could
facilit
macrophag
uptak
upon
lymph
node
entri
therebi
reduc
particl
escap
lymph
node
filter
mechan
sizedepend
lymph
node
target
also
observ
solid
particl
platform
studi
gao
et
al
compar
nm
nm
gold
nanoparticl
antigen
carrier
nm
gold
nanoparticl
yield
higher
lymph
node
accumul
term
total
gold
deliveri
upon
convers
particl
number
total
particl
surfac
area
nm
gold
nanoparticl
enhanc
compar
nm
particl
respect
gener
nanoparticl
nm
length
scale
coincid
viral
particl
exploit
interstiti
flow
lymphat
deliveri
within
length
scale
smaller
particl
size
tend
favor
lymph
node
accumul
given
privileg
nanocarri
lymphat
transport
nanoparticl
shown
enhanc
deliveri
target
antigen
lymph
node
resid
immun
cell
process
immun
activ
aforement
studi
polypropylen
sulfid
particl
instanc
reddi
et
al
demonstr
increas
resid
dendrit
cell
activ
lymph
node
ovalbuminconjug
nanoparticl
anim
studi
strong
antiovalbumin
humor
respons
observ
highlight
benefit
nanoparticlemedi
lymph
node
deliveri
enhanc
antigen
process
moon
et
al
also
show
nanoparticl
vaccin
promot
preferenti
accumul
antigen
drain
lymph
node
enhanc
expans
antigenspecif
cell
use
interbilayercrosslink
multilamellar
vesicl
icmv
lipidbas
nanoformul
consist
multipl
layer
lipid
vesicl
interconnect
via
thiol
chemistri
investig
demonstr
enhanc
antigen
deliveri
total
dc
macrophag
plasmacytoid
dc
lymph
node
interestingli
liposom
compar
size
much
less
effect
shuttl
antigen
drain
lymph
node
studi
observ
highlight
import
nanoparticl
stabil
vaccin
design
icmv
colloid
stabl
liposom
icmvmedi
antigen
deliveri
result
significantli
higher
humor
cellular
respons
compar
free
antigen
liposom
formul
effect
nanoparticl
carrier
antigen
transport
also
shown
studi
chen
et
al
demonstr
effect
vaccin
coronavirus
use
gold
nanoparticleadsorb
viral
antigen
antigenco
nanoparticl
structur
analog
coronavirus
term
size
antigen
display
immunofluoresc
quantif
show
viral
spike
protein
deliv
nm
gold
nanoparticl
increas
lymph
node
deliveri
approxim
compar
free
spike
protein
viruslik
particl
show
high
immunogen
murin
avian
model
enhanc
antivir
iga
igg
titer
cellular
immun
respons
comparison
free
protein
antigen
commerci
wiv
vaccin
addit
deliv
antigen
effect
immun
process
nanoparticl
extens
appli
local
immunolog
adjuv
lymph
node
improv
safeti
potenc
convent
adjuv
alum
wide
employ
clinic
promot
humor
respons
recent
develop
adjuv
research
identifi
mani
pathogenassoci
molecular
pattern
pamp
promis
adjuv
candid
toward
promot
humor
cellular
respons
molecular
danger
signal
often
similar
viral
pathogen
regard
immun
potenti
mechan
trigger
innat
immun
turn
facilit
adapt
immun
respons
mani
pamp
ie
cpgodn
poli
c
cyclic
dinucleotid
well
molecular
agonist
tolllik
receptor
tlr
ie
imiquimod
resiquimod
known
induc
strong
immun
respons
howev
potenc
pose
safeti
concern
like
induct
system
inflamm
nanoparticlebas
deliveri
thu
offer
desir
strategi
guid
immunolog
modul
lymph
node
increas
effect
concentr
reduc
system
reactogen
one
exampl
nunh
et
al
construct
phdegrad
nanogel
platform
ligat
imidazoquinolin
imdq
agonist
show
retent
adjuv
inject
site
drain
lymph
node
adjuv
free
form
elicit
system
inflammatori
respons
side
effect
larg
obviat
nanogel
formul
target
effect
nanoformul
also
result
recruit
monocyt
drain
lymph
node
larg
number
immun
cell
includ
b
cell
dc
macrophag
shown
readili
take
adjuvantload
nanogel
anoth
studi
ilyinskii
et
al
synthet
vaccin
particl
encapsul
resiquimod
ligand
augment
humor
cellular
immun
respons
solubl
nanoparticledeliv
protein
compar
observ
free
adjuv
adjuvantload
nanoparticl
promot
local
cytokin
induct
lymph
node
reduc
system
cytokin
product
observ
free
moreov
inject
nanoformul
led
sustain
express
lymph
node
hour
free
induc
modest
level
cpgodn
agonist
anoth
adjuv
frequent
coupl
nanocarri
vaccin
studi
primari
advantag
nanoparticlebas
cpg
formul
includ
strong
cell
respons
dosag
spare
reduc
system
side
effect
formul
commonli
appli
anticanc
vaccin
effort
owe
need
high
cellbas
immun
respons
effect
tumor
contain
transport
viral
antigen
immunepotenti
adjuv
virus
immun
cell
highli
coordin
event
viral
particl
shuttl
antigen
target
adjuv
nucleic
acid
simultan
antigenadjuv
coordin
absenc
shown
strongli
influenc
immun
cell
activ
addit
immun
system
respond
virus
multipl
pamp
includ
glycoprotein
dna
dsrna
ssrna
activ
broad
spectrum
signal
pathway
heighten
antivir
immun
synthet
flexibl
nanoparticl
thu
exploit
emul
codeliveri
capac
viral
pathogen
boost
immun
respons
case
antigen
adjuv
local
nanoparticl
synchron
deliveri
et
al
incorpor
hepat
b
surfac
antigen
hbsag
cpg
adjuv
onto
plga
nanoparticl
via
conjug
dopamin
allow
particl
display
viral
antigen
immun
activ
studi
show
pathogenmimick
particl
enhanc
recruit
immun
cell
inject
site
activ
bone
marrow
deriv
dendrit
cell
induc
strong
humor
cellular
immun
respons
anoth
studi
conduct
kuai
et
al
disclik
synthet
highdens
lipoprotein
shdl
appli
integr
target
antigen
cell
cpgodn
anticanc
vaccin
nanodisc
drastic
improv
codeliveri
antigen
adjuv
lymph
node
compar
solubl
vaccin
induc
enhanc
antigenspecif
cytotox
tlymphocyt
respons
compar
free
peptid
adjuv
control
besid
incorpor
antigen
adjuv
particl
codeliveri
number
studi
demonstr
deliv
antigen
adjuv
separ
similar
nanocarri
also
elev
antigenspecif
immun
respons
one
exampl
hiv
antigen
anchor
surfac
liposom
codeliv
liposom
formul
cdgmp
potent
agonist
sting
pathway
studi
show
substanti
accumul
sting
agonist
drain
lymph
node
expect
liposomebound
peptid
antigen
deliv
similar
fashion
result
enhanc
activ
antigen
present
cell
increas
level
antibodi
hiv
antigen
observ
immun
stimul
formul
contain
separ
antigenand
adjuvantload
nanoparticl
also
report
studi
explor
benefit
multiadjuv
load
particl
incorpor
multipl
distinct
activ
tlr
includ
monophosphoryl
lipid
agonist
agonist
kasturi
et
al
demonstr
adjuv
synerg
trigger
elev
antigenspecif
humor
respons
use
ovalbumin
hemagglutinin
influenza
virus
investig
demonstr
longlast
humor
respons
evid
memori
b
cell
format
follow
immun
nanoparticl
vaccin
exampl
highlight
function
versatil
synthet
nanoparticl
facilit
differ
mode
viru
mimicri
immun
activ
addit
role
lymph
node
trap
nanoscal
particl
immun
process
immun
system
also
adapt
repetit
antigen
display
virus
effect
potenti
viru
surfac
display
antigen
epitop
order
highli
repetit
fashion
present
repetit
arrang
appropri
space
antigen
surfac
viru
viruslik
particl
link
enhanc
immun
respons
mani
report
shown
numer
compon
mammalian
immun
system
evolv
respond
strongli
repetit
antigen
pattern
frequent
found
pathogen
comparison
nonrepetit
antigen
usual
less
effect
induc
immun
respons
repetit
motif
viral
surfac
also
found
activ
complement
system
engag
complex
facilit
b
cell
activ
amplifi
immun
process
pathway
understand
link
structur
featur
antigen
display
immunolog
induct
vital
design
nanoparticul
vaccin
multival
interact
promot
bcell
receptor
bcr
cluster
signal
facilit
receptormedi
intern
antigen
antigen
featur
epitop
affin
valenc
coreceptor
recruit
impact
b
cell
signal
studi
use
antigenconjug
polym
assay
impact
antigen
valenc
b
cell
activ
puffer
et
al
show
cluster
bcr
multival
antigen
crucial
antigendepend
signal
antigenconjug
polym
cluster
unbound
bcr
contribut
enhanc
intracellular
signal
wherea
multival
antigenpolym
conjug
elicit
antibodi
product
free
antigen
fail
trigger
humor
respons
fig
highli
repetit
surfac
also
known
bind
strongli
natur
igm
antibodi
multival
highavid
interact
antibodi
bind
also
facilit
cellular
uptak
particl
macrophag
dendrit
cell
turn
enhanc
immun
process
increas
antigen
present
also
worth
note
mani
import
compon
humor
arm
innat
immun
complement
pentraxin
ficolin
collectin
multimer
structur
favor
highavid
interact
repetit
pathogen
surfac
fig
observ
highlight
immun
system
prime
respond
repetit
motif
frequent
found
viral
particl
unlik
free
subunit
antigen
nanoparticl
vaccin
present
high
concentr
antigen
surfac
nanoparticl
surfac
function
hundr
antigen
effect
emul
antigen
display
viral
surfac
multival
antigen
display
nanoparticl
enhanc
antibodi
respons
effici
crosslink
bcr
activ
complement
facilit
antibodi
bind
factor
play
synergist
role
promot
b
cell
differenti
stimul
dcmediat
cell
prime
although
synthet
prepar
nanoparticl
yet
show
level
order
antigen
arrang
found
virus
viruslik
particl
deriv
cell
cultur
system
ongo
studi
continu
demonstr
emerg
techniqu
coupl
antigen
interest
nanocarri
last
section
review
review
commonli
use
method
coupl
antigen
nanoparticl
strategi
may
spur
novel
approach
prepar
nanoparticl
vaccin
associ
protein
antigen
nanoparticl
divid
particl
encapsul
surfac
associ
mani
studi
show
excel
nanoparticl
vaccin
potenc
encapsul
antigen
surfac
associ
antigen
may
benefit
innat
immun
factor
immun
process
mechan
describ
previou
section
techniqu
associ
protein
peptid
antigen
categor
multipl
categori
differ
mode
antigen
associ
highlight
follow
thiol
amin
group
protein
peptid
antigen
frequent
exploit
bioconjug
nanoparticl
thiol
group
cystein
amino
acid
power
nucleophil
capac
form
coval
linkag
sever
linker
group
maleimid
succinimidyl
propion
spdp
facilit
conjug
thiolcontain
antigen
nanoparticl
maleimidethiol
reaction
nucleophil
thiolat
anion
attack
maleimid
form
enol
intermedi
yield
desir
conjug
techniqu
wide
use
assembl
nanoparticl
vaccin
studi
refin
liposom
formul
hiv
vaccin
thiol
chemistri
exploit
control
physiolog
conform
densiti
target
antigen
modul
immun
respons
thiol
group
also
readili
associ
gold
surfac
strong
interact
sulfur
gold
drive
sulfur
atom
fill
free
orbit
gold
atom
creat
coordin
coval
bond
approach
extens
appli
associ
nucleic
acid
antigen
gold
nanoparticl
amin
group
hand
present
protein
peptid
antigen
link
nanocarri
via
amid
bond
format
typic
carbodiimid
crosslink
chemistri
bioconjug
aminecontain
antigen
commonli
perform
use
dimethylamino
propyl
carbodiimid
edc
nhydroxysuccinimid
nh
nh
sulfon
sulfonh
effici
coupl
carboxyl
group
aid
edc
form
nh
ester
nh
ester
coval
conjug
primari
amin
form
intermedi
compound
subsequ
hydrolys
desir
conjug
mani
nanoparticl
vaccin
prepar
edcnh
conjug
method
high
coupl
yield
polydopamin
function
anoth
conjug
approach
increasingli
appli
associ
protein
peptid
nanoparticl
alkalin
ph
dopamin
undergo
oxid
selfpolymer
form
layer
polydopamin
coat
almost
type
materi
mussellik
adhes
layer
enabl
secondari
reaction
biomolecul
contain
thiol
amin
group
techniqu
demonstr
organ
inorgan
nanoparticl
dopamineincorpor
polym
also
employ
adsorb
protein
macrophagetarget
deliveri
versatil
techniqu
appli
conjug
multipl
cargo
vaccin
applic
electrostat
attract
opposit
charg
antigen
nanoparticl
exploit
prepar
nanoparticl
vaccin
gener
cation
nanocarri
prepar
associ
anion
protein
antigen
case
liposom
cation
lipid
dotap
frequent
appli
render
nanocarri
posit
charg
dotapbas
liposom
shown
absorb
hpv
peptid
enhanc
antigenspecif
cell
respons
increas
antitumor
respons
strategi
also
employ
prepar
antigen
ad
anion
moieti
via
recombin
protein
engin
express
hpv
protein
ovalbumin
anion
lipoprotein
shen
et
al
demonstr
enhanc
antigen
associ
effici
retent
dotap
liposom
vaccin
formul
elev
antigenspecif
cellular
respons
inhibit
tumor
growth
mous
model
anoth
work
base
print
particl
replic
nonwet
templat
technolog
electrostat
interact
exploit
gener
nanoparticl
vaccin
cylindr
shape
cation
particl
prepar
blend
posit
charg
polym
plga
prior
imprint
lithographi
process
upon
mix
anion
hemagglutinin
protein
influenza
virus
high
level
antigen
bind
particl
surfac
achiev
immun
nanoparticl
vaccin
elicit
potent
antiinfluenza
antibodi
respons
compar
commerci
vaccin
base
inactiv
subunit
influenza
virus
unlik
spheric
nanoparticl
vaccin
platform
offer
abil
mimic
filament
shape
found
among
mani
viru
speci
synthet
nanoparticl
high
surfac
energi
owe
larg
radii
curvatur
result
adsorpt
protein
occur
spontan
owe
combin
weak
interact
forc
lead
format
protein
corona
format
phenomenon
demonstr
facilit
assembl
synthet
viruslik
nanoparticl
upon
mix
gold
nanoparticl
viral
antigen
rapid
protein
adsorpt
took
place
nanoparticl
surfac
adsorpt
led
colloid
stabil
gold
nanoparticl
prevent
aggreg
biolog
buffer
biochem
analysi
show
facil
assembl
method
surround
nanoparticl
approxim
coronaviru
spike
protein
induc
enhanc
antivir
immun
respons
adsorpt
approach
use
extens
associ
antigen
nanocarri
includ
nanoparticl
made
gold
calcium
phosphat
aluminium
hydroxid
carbon
silica
organ
polym
rang
adsorb
biomolecul
vari
dna
adjuv
small
peptid
protein
antigen
import
note
format
protein
corona
dynam
process
strongli
influenc
nanomateri
antigen
interest
studi
also
shown
antigen
undergo
conform
chang
upon
nanoparticl
adsorpt
could
posit
neg
effect
result
vaccin
formul
coat
nanoparticl
cellular
membran
emerg
function
approach
pave
way
novel
vaccin
formul
virusmimet
featur
shown
follow
dispers
cell
membran
vesicl
nanoparticl
highli
control
membran
coat
achiev
yield
unilamellar
membran
cloak
nanoparticl
retain
membran
protein
rightsideout
orient
nanoparticl
structur
analog
envelop
virus
consist
cellderiv
lipid
membran
stabil
via
viral
capsid
matrix
protein
membran
coat
approach
adapt
vaccin
prepar
cancer
bacteria
enhanc
dendrit
cell
activ
present
melanomaassoci
tumor
antigen
demonstr
fang
et
al
use
plga
nanoparticl
cloak
membran
enhanc
immun
respons
membran
antigen
attribut
increas
cellular
deliveri
coloc
immunolog
adjuv
facilit
nanoparticl
gao
et
al
also
show
bacteri
outer
membran
vesicl
omv
render
immunogen
follow
coat
gold
nanoparticl
omvcoat
nanoparticl
significantli
increas
antigen
deliveri
lymph
node
elev
product
cytokin
associ
bacteri
contain
membran
cloak
approach
offer
titil
strategi
toward
futur
vaccin
design
method
enabl
coupl
membraneanchor
antigen
nativ
conform
immunogen
nanocarri
advanc
nanotechnolog
adopt
vaccinolog
help
push
boundari
nonliv
subunit
vaccin
result
mani
excit
demonstr
effect
immun
potenti
nanoformul
nanoparticl
vaccin
enhanc
humor
respons
target
antigen
shown
promot
cellbas
immun
well
immunolog
memori
hallmark
good
vaccin
formul
often
inher
live
attenu
virus
increas
number
studi
shed
light
mechan
behind
benefit
nanoparticl
vaccin
includ
lymph
node
target
multival
antigen
display
coordin
deliveri
antigen
adjuv
featur
find
mechanist
analogu
immunolog
process
virus
given
frequent
semblanc
nanoparticl
vaccin
virus
regard
size
morpholog
antigen
display
adjuvant
effect
nanoparticl
present
compel
platform
bridg
gap
live
nonliv
vaccin
emerg
techniqu
nanoparticl
function
also
pave
way
novel
formul
design
promis
control
immun
modul
go
forward
understand
virolog
may
assist
scientist
engin
prepar
emerg
nanoformul
advanc
viruslik
featur
vaccin
nanotechnolog
envis
improv
vaccin
safeti
potenc
avail
offer
compel
platform
toward
address
mani
public
health
threat
yet
effect
prophylaxi
treatment
option
